Friday 6 November 2026
Export ALKS’s income statement to Excel — free account
Alkermes plc
ALKS Healthcare Drug Manufacturers Specialty & Generic
Alkermes plc’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 5.25% from fiscal 2024.
- Revenue
- +21.8%
- EPS
- −80.6%
- Free cash flow
- +6.78%
Quarter to September 2026, against a year earlier
45.66
1.12
+2.51%
Follow ALKS
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 4 | 7 |
+8 more TTM periods Free account |
| (0.02%) | 3.85% | 9.36% | 14.72% | ||
| (0.01%) | 1.99% | 4.82% | 10.64% | ||
ROIC |
1.54% | 2.76% | 4.36% | 31.75% | |
Return on Tangible Assets |
(0.03%) | 6.13% | 15.59% | 15.03% | |
Average Days of Receivables |
95.56 | 99.91 | 95.23 | 82.61 | |
Free Cash Flow per Share |
1.36 | 1.33 | 1.33 | 2.92 | |
Free Cash Flow |
228.43 | 222.71 | 221.18 | 481.42 | |
Capital Expenditures |
(14.55) | (28.47) | (35.02) | (39.33) | |
| Other line items | |||||
Cash ROIC |
5.55% | 5.61% | 5.86% | 15.34% | |
Accounts Receivable Turnover |
4.31 | 4.11 | 4.30 | 4.11 | |
Accounts Payable Turnover |
1.18 | 0.89 | 0.87 | 0.83 | |
Inventory Turnover |
1.33 | 1.05 | 0.80 | 1.04 | |
Average Days of Payables |
358.09 | 471.29 | 511.36 | 537.99 | |
Days of Inventory on Hand |
317.54 | 423.78 | 588.48 | 365.31 | |
Tax Rate |
(1.03) | (0.32) | (0.25) | (0.17) | |
Research and Development Expense of Revenue |
24.55% | 23.45% | 22.75% | 21.95% | |
Selling, General and Administrative Expense of Revenue |
50.06% | 50.44% | 50.85% | 47.53% | |
Share Based Compensation of Revenue |
6.87% | 7.10% | 7.18% | 6.69% | |
Interest Coverage |
0.81 | 2.04 | 5.12 | — | |
Operating CF/Net income |
(692.27) | 3.80 | 1.68 | 2.15 | |
Depreciation/Fixed assets |
0.71 | 0.48 | 0.24 | 0.12 | |
Capex/Depreciation |
(0.09) | (0.27) | (0.67) | (1.45) | |
Revenue per Share |
10.45 | 9.98 | 9.40 | 8.96 | |
Operating CF per Share |
1.45 | 1.50 | 1.54 | 3.16 | |
Capex per Share |
(0.09) | (0.17) | (0.21) | (0.24) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026